Valeant Pharmaceuticals To Host Investor Day
MONTREAL, June 7, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International (NYSE: VRX) (TSX: VRX) today announced that it will host an Investor Day in Florham Park, New Jersey, on Thursday, June 21, 2012 from 8:30 a.m. to 12:30 p.m. ET. J. Michael Pearson, Valeant's chairman and chief executive officer, and other members of Valeant's management team will discuss the company's strategies and opportunities in each of its business regions.
A live video webcast and slide presentation of the event will be available on the company's web site at www.valeant.com. To access the webcast select "Investor Relations" and find the event listed under "Events and Presentations." Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen and view to the Internet webcast. The webcast will be archived on the company's website for future on-demand replay.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.
Laurie W. Little
SOURCE Valeant Pharmaceuticals International, Inc.
More by this Source
Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results
Feb 27, 2014, 06:00 ET
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Feb 03, 2014, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.